Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
sunitinib or pazopanib
DRUG
2 trials
Sponsors
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
, RenJi Hospital
Conditions
Clear-cell Metastatic Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma
Phase 3
Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery
Terminated
NCT02535351
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Clear-cell Metastatic Renal Cell Carcinoma
Start: 2015-11-30
End: 2018-09-28
Updated: 2018-11-14
Unknown Phase
Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma
NCT05816642
RenJi Hospital
Metastatic Renal Cell Carcinoma
Start: 2022-08-01
End: 2024-12-31
Target: 500
Updated: 2023-04-18
Related Papers
TARIBO trial: Cytoreductive nephrectomy in metastatic renal cell carcinoma patients treated with targeted agents.
Journal of Clinical Oncology
2017-05-20
TARIBO trial: Targeted therapy with or without nephrectomy in metastatic renal cell carcinoma (mRCC)—Liquid biopsy for biomarkers discovery.
Journal of Clinical Oncology
2016-05-20
2 citations